or Try an Advanced Search...

    Targeted Therapy Stocks List

    Symbol Grade Name % Change
    CRDF B Cardiff Oncology, Inc. 2.72
    AVTX B Avalo Therapeutics, Inc. -0.35
    BCAB C BioAtla, Inc. 8.85
    ATRA C Atara Biotherapeutics, Inc. 8.98
    CELC D Celcuity Inc. -3.68
    APTO F Aptose Biosciences, Inc. -0.08
    OLMA F Olema Pharmaceuticals, Inc. 0.78
    CLRB F Cellectar Biosciences, Inc. -0.49
    POAI F Predictive Oncology Inc. -3.79
    APLM F Apollomics Inc. 0.08
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
    Related Stock Lists: Clinical Medicine Medicine Cancer Biopharmaceutical Oncology Drugs Solid Tumors Acute Myeloid Leukemia Antineoplastic Drugs Chemotherapy Advanced Solid Tumors Biology Biomarkers Biotechnology Cancer Immunotherapy Cancer Therapies Cell Biology Leukemia Non Small Cell Lung Cancer Ovarian Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Targeted Therapy stocks.

    Symbol Grade Name Weight
    BBC B Virtus LifeSci Biotech Clinical Trials ETF 1.55
    JFWD A Jacob Funds Inc. Jacob Forward ETF 0.91
    FORH C Formidable ETF 0.86
    SBIO B ALPS Medical Breakthroughs ETF 0.86
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 0.41
    View all Targeted Therapy ETFs...
    Compare ETFs
    Compare BBC to FORH Compare FORH to SBIO Compare JFWD to LABD

        Targeted Therapy Stocks Recent News

        Date Stock Title
        Nov 1 CLRB Cellectar Biosciences regains compliance with Nasdaq
        Nov 1 CLRB Cellectar Biosciences Announces Compliance Regarding Filing of Form 10-Q
        Oct 31 OLMA Here's Why We're Not Too Worried About Olema Pharmaceuticals' (NASDAQ:OLMA) Cash Burn Situation
        Oct 31 BCAB BioAtla to Announce Third Quarter 2024 Financial Results and Provide Business Highlights on November 7, 2024
        Oct 30 CRDF Cardiff Oncology Announces Journal of Clinical Oncology Publication of Data from Phase 2 Trial in Second-line KRAS Mutant mCRC
        Oct 30 BCAB BioAtla, Inc. (NASDAQ:BCAB) has caught the attention of institutional investors who hold a sizeable 39% stake
        Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
        Related Stock Lists: Clinical Medicine Medicine Cancer Biopharmaceutical Oncology Drugs Solid Tumors Acute Myeloid Leukemia Antineoplastic Drugs Chemotherapy Advanced Solid Tumors Biology Biomarkers Biotechnology Cancer Immunotherapy Cancer Therapies Cell Biology Leukemia Non Small Cell Lung Cancer Ovarian Cancer
        Targeted Therapy

        Targeted therapy is a type of cancer treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. It works by targeting the molecules and pathways that are involved in the growth and spread of cancer cells. Targeted therapy is used to treat many types of cancer, including breast, lung, and colorectal cancer.

        Browse All Tags